跳至主要内容
临床试验/CTRI/2021/11/038345
CTRI/2021/11/038345尚未招募未知

To evaluate the safety and efficacy of skin care regime with combination of Bristaa Intense Cream and Photostable Gold Sunscreen Gel in female subjects with melasma and dark spots. - N/AP

Sun Pharmaceutical Industries Limited0 个研究点目标入组 0 人开始时间: 待定最近更新:

试验速览

阶段
未知
状态
尚未招募

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

入选标准

  • 1 Having Fitz Patrick Skin type III-IV
  • 2 Having dark spots on face (with at least one dark spot ââ?°Â¥ 3.5mm in diameter) or having visible melasma on face (with mMASI score between 1-8)
  • 3 Having dull skin (i.e., skin that lacks brightness & has uneven skin tone based on visual assessment by experts)

排除标准

  • 1Female who is pregnant or breastfeeding or has stopped breastfeeding in the past three months
  • 2Participating in another study liable to interfere with this study
  • 3Having a chronic dermatosis liable to modify the cutaneous reactivity on the tested area
  • 4Being insulin-dependent diabetic or non insulin-dependent diabetic with a recent therapy (less than 6 months)
  • 5Having progressive asthma
  • Being epileptic
  • Having non stabilized thyroid problems
  • Having cutaneous hypersensitivity
  • Having a diagnosed or highly probable allergy to one or several compounds of the cosmetic products or food products or to latex
  • Following a chronic medicinal treatment comprising any of the following products: aspirin-based products, anti-inflammatories, anti-histamines, corticotherapy, taken by general or local routes (the only medication permitted is paracetamol) for more than 1 year.
  • Having undergone a surgery requiring a general anaesthetic of more than one hour in the past 6 months.
  • Having changed her cosmetic habits in the 14 days preceding the start of the study on the studied anatomic unit
  • Having applied a cosmetic product (included make-up) on the studied areas the first day of the study (only face cleaned with water is accepted)
  • Having started, changed or stopped a hormonal treatment (hormonal contraception, Hormone Replacement Therapy) in the past 3 months
  • For Smokers - Any change in smoking habits as below
  • -A person who was a non-smoker but has now started smoking >10 cigarettes per day in the last 6 months
  • -A person who was smoking <10 cigarettes per day but has started smoking >10 cigarettes per day in the last 6 months
  • -A person who was smoking >10 cigarettes per day but has now either stopped smoking or is smoking <10 cigarettes per day in the last 6 months
  • Having taken a medicinal treatment which could lead to hyper pigmentation (e.g. phenytoÃ?¯n, amiodarone, metals, minocycline) in the previous 6 months
  • Taking oral supplements or topical application with major or minor effect on whitening of skin (e.g. vitamin C, beta-carotene)
  • Having applied beauty treatment (e.g. skin cleansing, exfoliation, scrub, mask) or self-tanning products in the week preceding the start of the study
  • Having applied products with anti-wrinkle action (e.g. retinoic acid, retinol, retinaldehyde, isotretinoin, A.H.A.) in the 2 weeks preceding the start of the study
  • Having applied products with a depigmenting action (e.g. hydroquinone or derivates) in the 4 weeks preceding the start of the study
  • Having undergone physical and/or chemical treatments of the spots (e.g. liquid nitrogen, dry ice, pulsed flash lamp, dermabrasion, chemical peel) in the previous 6 months
  • Having a suntanned skin on the studied areas which could interfere with the evaluations of the study
  • Have taken any other treatment that in the opinion of the investigator could interfere with the evaluations of the study

研究者

相似试验